Previous investigations demonstrated that the abundance of infiltrating pro-inflammatory macrophages was significantly reduced in adipose tissue and liver of obese mice with Pik3 cg (-/-), leading to suppression of the inflammatory response in these tissues, establishing PIK3 CG as a promising therapeutic target for insulin resistance and type 2 diabetes [56]. Here, CTSG is linked to type 2 diabetes mellitus.